FEW vaccines have been so successful, so quickly, as MenAfriVac. It was introduced into Africa in 2010, to immunise people against meningitis A--a bacterial infection of the membranes surrounding the brain and the spinal cord, which can cause death or brain damage within hours of the onset of its flu-like symptoms. Since then, the caseload of the illness has plummeted to zero in 16 countries that used MenAfriVac in mass vaccination campaigns. Before the vaccine's introduction epidemics in the "m...
FEW vaccines have been so successful, so quickly, as MenAfriVac. It was introduced into Africa in 2010, to immunise people against meningitis A--a bacterial infection of the membranes surrounding the brain and the spinal cord, which can cause death or brain damage within hours of the onset of its flu-like symptoms. Since then, the caseload of the illness has plummeted to zero in 16 countries that used MenAfriVac in mass vaccination campaigns. Before the vaccine's introduction epidemics in the "m...
Share this Article
Recommended